Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Eder

Showing results (121-130 of 283) with videos related to

Pageof 29
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2016
PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617Clemens Kratochwil, Frederik L Giesel, Melsa Stefanova, et al.
Nature Methods|March 27, 2007
Ultramicroscopy: three-dimensional visualization of neuronal networks in the whole mouse brainHans-Ulrich Dodt, Ulrich Leischner, Anja Schierloh, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 5, 2016
Radiation dosimetry of (68)Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timingAli Afshar-Oromieh, Henrik Hetzheim, Wolfgang Kübler, et al.
Journal of Neurochemistry|March 30, 2010
Methylglyoxal-mediated anxiolysis involves increased protein modification and elevated expression of glyoxalase 1 in the brainBoris Hambsch, Bud-Gen Chen, Julia Brenndörfer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2016
Preclinical Evaluation of <sup>18</sup>F-PSMA-1007, a New Prostate-Specific Membrane Antigen Ligand for Prostate Cancer ImagingJens Cardinale, Martin Schäfer, Martina Benešová, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2014
Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate CancerMatthias Eder, Oliver Neels, Miriam Müller, et al.
Critical Care (London, England)|November 21, 2018
Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 yearsJulius J Schmidt, Catherina Lueck, Stefan Ziesing, et al.
Bioconjugate Chemistry|August 9, 2017
Improving the Imaging Contrast of <sup>68</sup>Ga-PSMA-11 by Targeted Linker Design: Charged Spacer Moieties Enhance the Pharmacokinetic PropertiesAnn-Christin Baranski, Martin Schäfer, Ulrike Bauder-Wüst, et al.
Cancer Research|February 24, 2021
Cytoplasmic Localization of Prostate-Specific Membrane Antigen Inhibitors May Confer Advantages for Targeted Cancer TherapiesJessica Matthias, Johann Engelhardt, Martin Schäfer, et al.
Cancers|February 25, 2022
Chemotherapy-Free Targeted Anti-BCR-ABL+ Acute Lymphoblastic Leukemia Therapy May Benefit the HeartHanna Kirchhoff, Melanie Ricke-Hoch, Katharina Wohlan, et al.
Pageof 29

Showing results (121-130 of 283) with videos related to

Sort By:
Pageof 29
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2016
PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617Clemens Kratochwil, Frederik L Giesel, Melsa Stefanova, et al.
Nature Methods|March 27, 2007
Ultramicroscopy: three-dimensional visualization of neuronal networks in the whole mouse brainHans-Ulrich Dodt, Ulrich Leischner, Anja Schierloh, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 5, 2016
Radiation dosimetry of (68)Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timingAli Afshar-Oromieh, Henrik Hetzheim, Wolfgang Kübler, et al.
Journal of Neurochemistry|March 30, 2010
Methylglyoxal-mediated anxiolysis involves increased protein modification and elevated expression of glyoxalase 1 in the brainBoris Hambsch, Bud-Gen Chen, Julia Brenndörfer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2016
Preclinical Evaluation of <sup>18</sup>F-PSMA-1007, a New Prostate-Specific Membrane Antigen Ligand for Prostate Cancer ImagingJens Cardinale, Martin Schäfer, Martina Benešová, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2014
Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate CancerMatthias Eder, Oliver Neels, Miriam Müller, et al.
Critical Care (London, England)|November 21, 2018
Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 yearsJulius J Schmidt, Catherina Lueck, Stefan Ziesing, et al.
Bioconjugate Chemistry|August 9, 2017
Improving the Imaging Contrast of <sup>68</sup>Ga-PSMA-11 by Targeted Linker Design: Charged Spacer Moieties Enhance the Pharmacokinetic PropertiesAnn-Christin Baranski, Martin Schäfer, Ulrike Bauder-Wüst, et al.
Cancer Research|February 24, 2021
Cytoplasmic Localization of Prostate-Specific Membrane Antigen Inhibitors May Confer Advantages for Targeted Cancer TherapiesJessica Matthias, Johann Engelhardt, Martin Schäfer, et al.
Cancers|February 25, 2022
Chemotherapy-Free Targeted Anti-BCR-ABL+ Acute Lymphoblastic Leukemia Therapy May Benefit the HeartHanna Kirchhoff, Melanie Ricke-Hoch, Katharina Wohlan, et al.
Pageof 29